JPH10147512A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPH10147512A JPH10147512A JP32108396A JP32108396A JPH10147512A JP H10147512 A JPH10147512 A JP H10147512A JP 32108396 A JP32108396 A JP 32108396A JP 32108396 A JP32108396 A JP 32108396A JP H10147512 A JPH10147512 A JP H10147512A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- ascorbic acid
- phosphate
- diethylene triamine
- hydroxyethanediphosphonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は、保存安定性に優
れ、色黒の皮膚を速やかに淡色化する、こじわを予防す
る、肌に潤いを与えるなどの効果に優れた皮膚化粧料に
関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin cosmetic which is excellent in storage stability, has excellent effects such as quickly lightening dark-skinned skin, preventing wrinkles, and moisturizing the skin.
【０００２】[0002]
【従来技術及び発明が解決しようとする課題】従来よ
り、メラニン生成を抑制し、肌のしみやそばかす等の予
防や治療する目的や、コラーゲン代謝を促進し、こじわ
を予防する目的で、また、肌に潤いを与える目的でＬ−
アスコルビン酸が配合されている。2. Description of the Related Art Conventionally, for the purpose of suppressing melanin production, preventing or treating skin spots and freckles, promoting collagen metabolism and preventing wrinkles, L- for moisturizing skin
Contains ascorbic acid.
【０００３】Ｌ−アスコルビン酸は、化粧料に配合した
場合、保存安定性が不十分である。このため、Ｌ−アス
コルビン酸を化学修飾した各種誘導体が開発されてい
る。[0003] L-ascorbic acid has insufficient storage stability when incorporated into cosmetics. For this reason, various derivatives obtained by chemically modifying L-ascorbic acid have been developed.
【０００４】Ｌ−アスコルビン酸−２−リン酸ナトリウ
ム、Ｌ−アスコルビン酸−２−リン酸マグネシウムなど
のＬ−アスコルビン酸−２−リン酸塩は、Ｌ−アスコル
ビン酸を安定化する目的で開発された誘導体である。し
かし、これを配合した化粧料においても、長期保存で黄
変、変臭が生じるなど安定性が十分でなく、また、これ
に伴って有用性も低下するなどの問題点があった。[0004] L-ascorbic acid-2-phosphate salts such as sodium L-ascorbic acid-2-phosphate and magnesium L-ascorbic acid-2-phosphate have been developed for the purpose of stabilizing L-ascorbic acid. Derivative. However, even cosmetics containing the same have problems such as insufficient stability such as yellowing and unpleasant odor when stored for a long period of time, and a reduction in usefulness.
【０００５】そこで本発明者らは鋭意研究した結果、下
記の皮膚化粧料が、Ｌ−アスコルビン酸−２−リン酸塩
の黄変、変臭等を抑制し保存安定性に優れ、その結果、
美白効果、こじわを予防する、肌に潤いを与えるなどの
美肌効果に優れていることを見出し、本発明を完成する
に至った。The inventors of the present invention have conducted intensive studies and have found that the following skin cosmetics suppress the yellowing and odor of L-ascorbic acid-2-phosphate and have excellent storage stability.
The inventors have found that they have excellent skin whitening effects such as whitening effect, prevention of wrinkles, and moisturizing the skin, and have completed the present invention.
【０００６】本発明の目的は、保存安定性に優れ、色黒
の皮膚を速やかに淡色化する、こじわを予防する、肌に
潤いを与えるなどの効果に優れた皮膚化粧料を提供する
ことにある。[0006] An object of the present invention is to provide a skin cosmetic composition which is excellent in storage stability, is effective in quickly lightening dark-skinned skin, preventing wrinkles, and moisturizing the skin. It is in.
【０００７】[0007]
【課題を解決するための手段】上記目的を達成する本発
明は、Ｌ−アスコルビン酸−２−リン酸塩と、ヒドロキ
シエタンジホスホン酸塩及びジエチレントリアミン五酢
酸塩の中から選ばれる少なくとも一種を含有する皮膚化
粧料である。SUMMARY OF THE INVENTION The present invention for achieving the above object comprises L-ascorbic acid-2-phosphate and at least one selected from hydroxyethanediphosphonate and diethylenetriaminepentaacetic acid. Skin cosmetics.
【０００８】[0008]
【発明の実施の形態】以下、本発明の実施の形態を詳述
する。Embodiments of the present invention will be described below in detail.
【０００９】本発明に用いられるＬ−アスコルビン酸−
２−リン酸塩は、例えばＬ−アスコルビン酸−２−リン
酸ナトリウム、Ｌ−アスコルビン酸−２−リン酸マグネ
シウム、Ｌ−アスコルビン酸−２−リン酸カリウム、Ｌ
−アスコルビン酸−２−リン酸カルシウム、Ｌ−アスコ
ルビン酸−２−リン酸アンモニウム等が挙げられるが、
これらに限定されるものではない。L-ascorbic acid used in the present invention
The 2-phosphate is, for example, sodium L-ascorbic acid-2-phosphate, magnesium L-ascorbic acid-2-phosphate, potassium L-ascorbic acid-2-phosphate,
-Ascorbic acid-2-calcium phosphate, L-ascorbic acid-2-ammonium phosphate and the like,
It is not limited to these.
【００１０】その含有量は、化粧料の処方成分全量を基
準として、０．００１〜３０重量％が好ましく、更に好
ましくは０．０１〜１０重量％の範囲内である。０．０
０１重量％未満では美白、美肌効果が得られにくく、３
０重量％を超えると沈殿や結晶が生じやすくなるため、
好ましくないことがある。The content is preferably 0.001 to 30% by weight, more preferably 0.01 to 10% by weight, based on the total amount of the cosmetic ingredients. 0.0
If it is less than 01% by weight, it is difficult to obtain a whitening effect and a beautiful skin effect.
If the content exceeds 0% by weight, precipitation and crystals tend to occur.
May not be preferred.
【００１１】本発明に用いられるヒドロキシエタンジホ
スホン酸塩としては、ヒドロキシエタンジホスホン酸四
ナトリウム、ヒドロキシエタンジホスホン酸三ナトリウ
ム、ヒドロキシエタンジホスホン酸二ナトリウム、ヒド
ロキシエタンジホスホン酸ナトリウム、ヒドロキシエタ
ンジホスホン酸四カリウム、ヒドロキシエタンジホスホ
ン酸三カリウム、ヒドロキシエタンジホスホン酸二カリ
ウム、ヒドロキシエタンジホスホン酸カリウムなどが挙
げられるが、これらに限定されない。The hydroxyethanediphosphonate used in the present invention includes tetrasodium hydroxyethanediphosphonate, trisodium hydroxyethanediphosphonate, disodium hydroxyethanediphosphonate, sodium hydroxyethanediphosphonate, and hydroxyethane. Examples include, but are not limited to, tetrapotassium diphosphonate, tripotassium hydroxyethanediphosphonate, dipotassium hydroxyethanediphosphonate, potassium hydroxyethanediphosphonate, and the like.
【００１２】本発明に用いられるジエチレントリアミン
五酢酸塩としては、ジエチレントリアミン五酢酸五ナト
リウム、ジエチレントリアミン五酢酸四ナトリウム、ジ
エチレントリアミン五酢酸三ナトリウム、ジエチレント
リアミン五酢酸二ナトリウム、ジエチレントリアミン五
酢酸ナトリウム、ジエチレントリアミン五酢酸五カリウ
ム、ジエチレントリアミン五酢酸四カリウム、ジエチレ
ントリアミン五酢酸三カリウム、ジエチレントリアミン
五酢酸二カリウム、ジエチレントリアミン五酢酸カリウ
ムなどが挙げられるが、これらに限定されるものではな
い。The diethylene triamine pentaacetate used in the present invention includes pentasodium diethylene triamine pentaacetate, tetrasodium diethylene triamine pentaacetate, trisodium diethylene triamine pentaacetate, disodium diethylene triamine pentaacetate, sodium diethylene triamine pentaacetate, pentapotassium diethylene triamine pentaacetate, Examples include, but are not limited to, tetrapotassium diethylenetriaminepentaacetate, tripotassium diethylenetriaminepentaacetate, dipotassium diethylenetriaminepentaacetate, potassium diethylenetriaminepentaacetate, and the like.
【００１３】ヒドロキシエタンジホスホン酸塩及びジエ
チレントリアミン五酢酸塩の中から選ばれる少なくとも
一種の配合量は化粧料全量中、０．００１〜３０重量％
が好ましく、更に好ましくは０．０１〜１０重量％であ
る。０．００１重量％未満では十分な効果が得られず、
３０重量％を超えると沈殿や結晶が生じやすくなるため
好ましくないことがある。The amount of at least one compound selected from the group consisting of hydroxyethanediphosphonate and diethylenetriaminepentaacetic acid is 0.001 to 30% by weight based on the total amount of the cosmetic.
And more preferably 0.01 to 10% by weight. If the content is less than 0.001% by weight, a sufficient effect cannot be obtained.
If it exceeds 30% by weight, precipitation and crystals tend to occur, which is not preferable.
【００１４】Ｌ−アスコルビン酸−２−リン酸ナトリウ
ムと、ヒドロキシエタンジホスホン酸塩及びジエチレン
トリアミン五酢酸塩から選択される成分の和との配合比
率は、重量で１００：１〜１：５０が好ましく、更に好
ましくは３０：１〜１：１０である。The compounding ratio of sodium L-ascorbic acid-2-phosphate to the sum of components selected from hydroxyethanediphosphonate and diethylenetriaminepentaacetate is preferably 100: 1 to 1:50 by weight. And more preferably 30: 1 to 1:10.
【００１５】本発明の化粧料には上記原料の他に、色
素、香料、防腐剤、界面活性剤、顔料、抗酸化剤、保湿
剤、紫外線吸収剤などを、本発明の目的を達成する範囲
内で適宜配合することができる。In the cosmetic of the present invention, in addition to the above-mentioned raw materials, pigments, fragrances, preservatives, surfactants, pigments, antioxidants, humectants, ultraviolet absorbers, etc. are included in the range for achieving the object of the present invention. Can be appropriately blended.
【００１６】本発明の化粧料の剤型としては、クリー
ム、乳液、化粧水、パックなどが挙げられる。この化粧
料は、例えば乳液等の場合、油相及び水相をそれぞれ加
熱溶解したものを乳化分散して冷却する通常の方法によ
り製造することができる。The cosmetic preparation of the present invention includes creams, emulsions, lotions, packs and the like. For example, in the case of an emulsion or the like, this cosmetic can be produced by a usual method of emulsifying and dispersing an oil phase and an aqueous phase, each of which is heated and dissolved, and cooling.
【００１７】[0017]
【実施例】以下、実施例及び比較例に基づいて本発明を
詳述する。実施例に記載の保存安定性試験法、皮膚色明
度回復試験法、実用テストは下記のとおりである。The present invention will be described below in detail based on examples and comparative examples. The storage stability test method, skin color lightness recovery test method, and practical test described in the examples are as follows.
【００１８】なお、実施例等で用いられる本発明に係わ
る化合物の略号をそれぞれ次の括弧に示す。Ｌ−アスコ
ルビン酸−２−リン酸ナトリウム（ＡＰＳ）、Ｌ−アス
コルビン酸−２−リン酸マグネシウム（ＡＰＭ）、Ｌ−
アスコルビン酸−２−リン酸カリウム（ＡＰＫ）、ヒド
ロキシエタンジホスホン酸四ナトリウム（ＨＥＰ４Ｎ
ａ）、ヒドロキシエタンジホスホン酸三ナトリウム（Ｈ
ＥＰ３Ｎａ）、ヒドロキシエタンジホスホン酸ナトリウ
ム（ＨＥＰＮａ）、ヒドロキシエタンジホスホン酸二カ
リウム（ＨＥＰ２Ｋ）、ジエチレントリアミン五酢酸五
ナトリウム（ＤＥＴＡ５Ｎａ）、ジエチレントリアミン
五酢酸四カリウム（ＤＥＴＡ４Ｋ）、ジエチレントリア
ミン五酢酸三カリウム（ＤＥＴＡ３Ｋ）、ジエチレント
リアミン五酢酸二カリウム（ＤＥＴＡ２Ｋ）、ジエチレ
ントリアミン五酢酸カリウム（ＤＥＴＡＫ）The abbreviations of the compounds according to the present invention used in the examples and the like are shown in the following parentheses. L-ascorbic acid-2-sodium phosphate (APS), L-ascorbic acid-2-magnesium phosphate (APM), L-
Potassium ascorbic acid-2-phosphate (APK), tetrasodium hydroxyethanediphosphonate (HEP4N
a), trisodium hydroxyethanediphosphonate (H
EP3Na), sodium hydroxyethanediphosphonate (HEPNa), dipotassium hydroxyethanediphosphonate (HEP2K), pentasodium diethylenetriaminepentaacetate (DETA5Na), tetrapotassium diethylenetriaminepentaacetate (DETA4K), tripotassium diethylenetriaminepentaacetate (DETA3K) , Dipotassium diethylenetriaminepentaacetate (DETA2K), potassium diethylenetriaminepentaacetate (DETAK)
【００１９】（１）保存安定性試験 同一試料を温度５℃、４５℃の恒温槽に３か月間保存し
た後、両者の経日における外観（色）、においの変化を
比較した。判定結果は５℃保存品と比較したときの４５
℃保存品の色、においの差異を下記の判定基準により
◎、○、△、×で示した。(1) Storage stability test The same sample was stored in a thermostat at a temperature of 5 ° C. and 45 ° C. for 3 months, and the appearance (color) and odor change of the two samples over time were compared. The judgment result was 45 when compared with the product stored at 5 ° C.
Differences in color and odor of the products stored at ℃ were indicated by ◎, △, Δ and × according to the following criteria.
【００２０】 [0020]
【００２１】 [0021]
【００２２】（２）皮膚色明度回復試験法 被験者２０名の背部皮膚にＵＶ−Ｂ領域の紫外線を最小
紅斑量の２倍照射し、試料塗布部位と非塗布部位を設定
して各々の皮膚の基準明度（Ｖ0 値，Ｖ0 ´値）を測定
した。引き続いて塗布部位には試料を１日２回ずつ１５
週間連続塗布した後、３，６，９，１２，１５週間後の
塗布部位及び非塗布部位の皮膚の明度（Ｖn 値，Ｖn ´
値）を測定し、下記の判定基準にしたがって皮膚色の回
復を評価した。尚、皮膚の明度（マンセル表色系Ｖ値）
は高速分光色彩計で測定して得られたＸ，Ｙ，Ｚ値より
算出した。また評価は被験者２０名ついて、６週間後の
評価点の平均値で示した。(2) Skin color lightness recovery test method The UV light in the UV-B region was irradiated to the back skin of 20 subjects twice as much as the minimum erythema dose. The reference lightness (V0 value, V0 'value) was measured. Subsequently, the sample was applied to the application site twice a day for 15 times.
After continuous application for three weeks, the lightness (Vn value, Vn ') of the skin at the application site and the non-application site after 3, 6, 9, 12, and 15 weeks
Was measured, and the recovery of skin color was evaluated according to the following criteria. The lightness of the skin (Munsell color system V value)
Was calculated from the X, Y, and Z values obtained by measuring with a high-speed spectral colorimeter. The evaluation was shown by the average value of the evaluation points after 6 weeks for 20 subjects.
【００２３】 [0023]
【００２４】（３）実用テスト（こじわ改善、保湿性） 被験者２５名に試料を顔面に連用させ、こじわ改善効
果、保湿効果について、連用１か月後の状態を連用前と
比較して評価した。評価は「こじわが改善された」「肌
に潤いがでた」と回答した人の人数で結果を示した。(3) Practical Test (Improvement of Ripple, Moisturizing Property) A sample was continuously applied to the face of 25 subjects, and the effect of improving the moisturizing and moisturizing effect was compared one month after continuous use with that before continuous use. evaluated. The evaluation was based on the number of people who answered that "the wrinkles were improved" and "the skin was moistened".
【００２５】実施例１〜６，比較例１〜３ Ｌ−アスコルビン酸−２−リン酸塩と、ヒドロキシエタ
ンジホスホン酸塩及びジエチレントリアミン五酢酸塩の
中から選ばれる少なくとも一種を表１の組成において配
合し、下記の調製方法に基づいてスキンクリームを調製
した。各々について前記の試験を実施し、その結果を表
２及び表３に示した。組成Examples 1 to 6, Comparative Examples 1 to 3 L-ascorbic acid-2-phosphate and at least one selected from hydroxyethanediphosphonate and diethylenetriaminepentaacetate in the composition shown in Table 1 And a skin cream was prepared based on the following preparation method. The above-mentioned test was performed for each, and the results are shown in Tables 2 and 3. composition
【００２６】[0026]
【表１】 [Table 1]
【００２７】[0027]
【表２】 [Table 2]
【００２８】[0028]
【表３】 [Table 3]
【００２９】調製方法 （Ａ）を７０℃、Ｂを５０℃にて均一に溶解し、（Ａ）
を攪拌しながら（Ｂ）を（Ａ）に注入して乳化分散した
後、攪拌しながら温度３０℃まで冷却して調製する。Preparation method (A) was uniformly dissolved at 70 ° C. and B was uniformly dissolved at 50 ° C.
After stirring (B) into (A) while stirring to emulsify and disperse, the mixture is cooled to 30 ° C. while stirring to prepare.
【００３０】特性 本発明の実施例１〜６のスキンクリームは、保存安定性
に優れ、各種有用性にも優れていた。一方、比較例１〜
３のスキンクリームは、保存安定性が悪く、また十分な
効果が認められず、本発明の実施例に比べて劣ってい
た。Characteristics The skin creams of Examples 1 to 6 of the present invention were excellent in storage stability and various usefulness. On the other hand, Comparative Examples 1 to
The skin cream No. 3 had poor storage stability and did not show a sufficient effect, and was inferior to the examples of the present invention.
【００３１】実施例７ ［スキンローション］ 表４の組成により本発明のスキンローションを下記の製
法によって調製した。 組成Example 7 Skin Lotion A skin lotion of the present invention having the composition shown in Table 4 was prepared by the following method. composition
【００３２】[0032]
【表４】 [Table 4]
【００３３】調製法 （Ａ），（Ｂ）の各成分をそれぞれ混合溶解し、（Ｂ）
を（Ａ）に加えて混合攪拌して調製した。Preparation method Each component of (A) and (B) is mixed and dissolved, and (B)
Was added to (A) and mixed and stirred.
【００３４】特性 この実施例７のスキンローションは、保存安定性に優
れ、各種有用性試験において良好な結果を示した。Properties The skin lotion of Example 7 was excellent in storage stability and showed good results in various usefulness tests.
【００３５】実施例８ ［デイエッセンス］ 表５の組成により本発明のデイエッセンス（日中用美容
液）を下記の製法によって調製した。 組成Example 8 [Day Essence] The day essence (daytime serum) of the present invention was prepared according to the composition shown in Table 5 by the following method. composition
【００３６】[0036]
【表５】 * ，**：ジボダン社製[Table 5] *, **: Givaudan
【００３７】調製法 （Ａ）を７０℃，（Ｂ）を５０℃にて各成分をそれぞれ
混合溶解し、（Ｂ）を（Ａ）に加えて混合攪拌し、３０
℃まで冷却して調製した。Preparation Method (A) was mixed and dissolved at 70 ° C. and (B) at 50 ° C., and each component was mixed and dissolved. (B) was added to (A), and mixed and stirred.
Prepared by cooling to ° C.
【００３８】特性 この実施例８のデイエッセンスは、保存安定性に優れ、
各種有用性試験において良好な結果を示した。Characteristics The deessence of Example 8 has excellent storage stability.
Good results were obtained in various usefulness tests.
【００３９】[0039]
【発明の効果】以上記載のごとく、本発明が、保存安定
性に優れ、色黒の皮膚を速やかに淡色化する、こじわを
予防する、肌に潤いを与えるなどの効果に優れた皮膚化
粧料を提供することは明らかである。Industrial Applicability As described above, the present invention is a skin cosmetic having excellent storage stability and excellent effects such as quick lightening of dark-skinned skin, prevention of wrinkles, and moisturizing the skin. It is clear that the fee is provided.
Claims (1)
ヒドロキシエタンジホスホン酸塩及びジエチレントリア
ミン五酢酸塩の中から選ばれる少なくとも一種を含有す
る皮膚化粧料。1. An L-ascorbic acid-2-phosphate salt,
Skin cosmetics containing at least one selected from hydroxyethane diphosphonate and diethylene triamine pentaacetate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32108396A JP3517068B2 (en) | 1996-11-15 | 1996-11-15 | Skin cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32108396A JP3517068B2 (en) | 1996-11-15 | 1996-11-15 | Skin cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10147512A true JPH10147512A (en) | 1998-06-02 |
| JP3517068B2 JP3517068B2 (en) | 2004-04-05 |
Family
ID=18128629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP32108396A Expired - Lifetime JP3517068B2 (en) | 1996-11-15 | 1996-11-15 | Skin cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3517068B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002007698A3 (en) * | 2000-07-26 | 2002-07-18 | Basf Ag | Cosmetic or dermatological preparations for avoiding skin damage caused by peroxide |
| JP2013227264A (en) * | 2012-04-27 | 2013-11-07 | Mikimoto Pharmaceut Co Ltd | External preparation for skin |
| US10945945B2 (en) | 2016-12-22 | 2021-03-16 | Conopco, Inc. | Stabilization of cosmetic compositions comprising fish oils and hydroxylated fatty acids and/or its derivatives |
-
1996
- 1996-11-15 JP JP32108396A patent/JP3517068B2/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002007698A3 (en) * | 2000-07-26 | 2002-07-18 | Basf Ag | Cosmetic or dermatological preparations for avoiding skin damage caused by peroxide |
| JP2013227264A (en) * | 2012-04-27 | 2013-11-07 | Mikimoto Pharmaceut Co Ltd | External preparation for skin |
| US10945945B2 (en) | 2016-12-22 | 2021-03-16 | Conopco, Inc. | Stabilization of cosmetic compositions comprising fish oils and hydroxylated fatty acids and/or its derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3517068B2 (en) | 2004-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3354768B2 (en) | Skin cosmetics | |
| JPH03153609A (en) | Skin-beautifying cosmetic | |
| JPS61207312A (en) | Skin-beautifying cosmetic | |
| JP3517068B2 (en) | Skin cosmetics | |
| JP2684615B2 (en) | Skin cosmetics | |
| JPH049310A (en) | Emulsified cosmetic | |
| JP3229517B2 (en) | Whitening cosmetics | |
| JP2613865B2 (en) | Cosmetics | |
| JPH10182404A (en) | Preparation for external use for skin | |
| JP2719273B2 (en) | Skin cosmetics | |
| JP2708692B2 (en) | Whitening cosmetics | |
| JPH0363207A (en) | Skin cosmetic | |
| JP2744485B2 (en) | Whitening cosmetics | |
| JP2824229B2 (en) | Skin cosmetics | |
| JPH0733639A (en) | Beautifying and whitening cosmetic | |
| JP3045604B2 (en) | Whitening cosmetics | |
| JPS62298508A (en) | Skin cosmetic | |
| JPH03153610A (en) | Skin-beautifying cosmetic | |
| JP3673424B2 (en) | Cosmetics | |
| JP2004256412A (en) | Skin care preparation composition for external use | |
| JPH10194955A (en) | Skin cosmetic | |
| JP2681895B2 (en) | Skin cosmetics | |
| JPH05345714A (en) | Skin cosmetic | |
| JP3229594B2 (en) | Whitening cosmetics | |
| JPH0672842A (en) | Beautifully whitening cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040120 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040122 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080130 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090130 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090130 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100130 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110130 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110130 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120130 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120130 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130130 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130130 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140130 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |